Form 4: Century Therapeutics SVP Sells Shares for Tax Obligations Following RSU Vesting

Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc., sold 4,904 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Douglas Carr, SVP Finance & Operations of Century Therapeutics, Inc. (IPSC), reported a transaction on June 9, 2025.
• The transaction involved the sale of 4,904 shares of Century Therapeutics common stock.
• The shares were sold at a price of $0.622 per share.
• The sale was non-discretionary and executed automatically to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Carr beneficially owns 405,982 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale to cover tax obligations related to RSU vesting, which is a common occurrence for executive compensation and does not imply a change in management's outlook or confidence in the company.

Negatives

• The transaction represents an insider sale of common stock, although it was non-discretionary and for tax purposes.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• "The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."

Industry Context

This filing is a routine insider transaction report, common for executives receiving equity compensation. It does not reflect broader industry trends or competitive dynamics within the biotechnology or pharmaceutical sector.

Stakeholder Impact

• Shareholders: The sale is a routine, non-discretionary event for tax purposes and is unlikely to have a significant impact on shareholder perception or share price.
• Employees: The transaction is related to executive compensation, which is standard practice.

Key Dates

Keywords

Century Therapeutics, IPSC, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Douglas Carr, Beneficial Ownership